INDP Indaptus Therapeutics Inc Net earnings per share growth forecast for next year
Indaptus Therapeutics is developing a scalable bacterial immuno-oncology platform, monetizing patents through royalties from pharma behemoths. Reviewing the 12-month EPS growth targets on GURU.Markets, we see that the 0.00 level reflects fresh values. Indaptus Therapeutics is implementing a bold method of training the body to fight cancer using inactivated bacteria, targeting growing demand within the early clinical trials segment.
Analytical breakdowns for indaptusrx.com (INDP)
- stock quotes and analyst forecast:
- market capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
Debt to Equity Indaptus Therapeutics|INDP - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Indaptus Therapeutics, Inc.|INDP - Company Aggregate Debt|Debts to Book Capitalization Indaptus Therapeutics|INDP - Company Long-Term Debts|Company Short-Term Debt Indaptus Therapeutics|Quick Liquidity Indicator indaptusrx.com
- earnings and valuation multiples information:
INDP - Profit After Payment of Taxes|Future Profit Indaptus Therapeutics|INDP - P/E Multiple|Future Price to Earnings Indaptus Therapeutics|INDP - Growth-Adjusted Market Cap to Net Income|Enterprise Value to EBITDA Ratio Indaptus Therapeutics|INDP - Income before deduction of interest, taxes and amortization|Net earnings per share for the last 12 months Indaptus Therapeutics|INDP - Earnings per share for the last four quarters|Quarterly EPS earnings growth indaptusrx.com|INDP - Earnings per share increase in current year|Earnings growth forecast for next year Indaptus Therapeutics
General company analysis:Indaptus, INDP
The stability of the biomedical sector and its humanitarian status provide Indaptus Therapeutics (INDP) with a resilient operational backdrop shielded from geopolitical shocks. This projected net income trend chart visualizes daily changes in analysts' consensus estimates for future earnings per share, allowing investors to gauge market optimism and fundamental confidence in the business's capitalization through the lens of expected profit growth.
Main competitors
Expected earnings per share growth for next year ARGX|Earnings growth forecast for next year BioNTech Pharma|Net earnings per share growth forecast for next year Abivax (ABVX)|admabiologics.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PTGX (Protagonist)|Immunovant Inc (IMVT) - Expected net earnings per share growth next year|Kiniksa Pharmaceuticals Ltd - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Grifols Biemat GRFS|Adaptive Biotechnologies (ADPT) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year CLDX|AUPH (Aurinia Pharmaceuticals Inc.) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year BCRX (BioCryst Pharmaceuticals, Inc.)|Earnings growth forecast for next year VERA|Earnings growth forecast for next year Dianthus Corp (DNTH)|Net earnings per share growth forecast for next year Pharvaris N.V. PHVS|ABCL (abcellera.com) - Net earnings per share change forecast for next year|TRML: Expected earnings per share growth for next year|Precigen Inc - Projected earnings per share increase next year|PHAR (Pharming) - Expected earnings per share growth for next year|Nektar Corp (NKTR) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Upstream Bio Inc|zenasbio.com (ZBIO) - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year IMNM (Immunome)|GOSS (Gossamer Bio Inc) - Expected earnings per share trend next year|KalVista Pharmaceuticals Inc - Expected earnings per share growth for next year|Projected earnings per share increase next year SEPN (Septerna Pharma)|Pieris Pharmaceuticals - Earnings growth forecast for next year|Expected earnings per share trend next year SVRA (savarapharma.com)|RIGL: Earnings growth forecast for next year|Expected net earnings per share growth next year AnaptysBio Inc (ANAB)|Net earnings per share growth forecast for next year Astria Pharma|ENGN: Expected earnings per share trend next year|Earnings growth forecast for next year RAPT|Earnings growth forecast for next year aerovatetx.com (JBIO)|Net earnings per share growth forecast for next year Aclaris Therapeutics, Inc. ACRS|KYTX (Kyverna Therapeutics Inc.) - Net earnings per share change forecast for next year|Tiziana Life Sciences PLC - Earnings growth forecast for next year|Expected net earnings per share growth next year Cabaletta Bio Inc|VTYX (Ventyx Biosciences) - Expected earnings per share growth for next year|theratech.com (THTX) - Earnings growth forecast for next year|Expected earnings per share growth for next year AVTX|ELDN (Eledon Pharmaceuticals Inc.) - Projected earnings per share increase next year|Earnings growth forecast for next year AGEN|Consensus forecast of earnings per share growth for next year Climb Bio, Inc|Earnings growth forecast for next year ZURA (Zura Bio Limited)|ATYR - Expected earnings per share growth for next year|ADAG - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year ImageneBio Inc IMA|STTK: Earnings growth forecast for next year|EQ - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Connect Biopharma Holdings|Projected earnings per share growth rate for next year IMUX (Immunic Inc)|Earnings growth forecast for next year ATRA|inflarx.de - Projected earnings per share growth rate for next year|Net earnings per share growth forecast for next year X4 Pharma XFOR|ACET (Adicet Bio Inc.) - Net earnings per share change forecast for next year|CELU - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year INMB|BRNS: Earnings growth forecast for next year|Kezar Life Sciences Inc. - Expected earnings per share trend next year|SABS (SAB Biotherapeutics, Inc) - Earnings growth forecast for next year|Earnings growth forecast for next year Akari Therapeutics, Plc|Net earnings per share growth forecast for next year Enlivex Therapeutics (ENLV)|QTTB (q32bio.com) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year GeoVax GOVX|EDSA - Expected earnings per share growth for next year|iBio Corp - Earnings growth forecast for next year|CARM - Earnings growth forecast for next year|XTLB (XTL Biopharmaceuticals) - Expected earnings per share growth for next year|Bolt Biotherapeutics, Inc. - Expected earnings per share trend next year|HCWB (HCW Biologics, Inc.) - Earnings growth forecast for next year|Aptevo (APVO) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year AIM ImmunoTech (AIM)|Expected earnings per share growth for next year aditxt.com ADTX|Net earnings per share growth forecast for next year GRI Bio, Inc. GRI|XRTX - Expected earnings per share growth for next year|HIND: Expected earnings per share growth for next year|REVB - Earnings growth forecast for next year|Scinai (SCNI) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year CALI|AFMD (Affimed NV) - Earnings growth forecast for next year|Expected net earnings per share growth next year Allakos Therapeutics ALLK|Earnings growth forecast for next year HOOK|Consensus forecast of earnings per share growth for next year igmbio.com|Net earnings per share growth forecast for next year iTeos ITOS|OCEA: Projected earnings per share growth rate for next year|TC Biopharm - Earnings growth forecast for next year|THRD (thirdharmonicbio.com) - Projected earnings per share growth rate for next year
